Evidence and values: paying for end-of-life drugs in the British NHS

E-ISSN： 1744-134x|7|4|393-409

ISSN： 1744-1331

Source： Health Economics, Policy and Law, Vol.7, Iss.4, 2012-10, pp. : 393-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valuing end-of-life care in the United States: the case of new cancer drugs

Health Economics, Policy and Law, Vol. 7, Iss. 4, 2012-10 ,pp. : 411-430

Cambridge University Press

Access to resources Recommend Favorite

Modelling and evaluating product end-of-life options

By Erdos G. Kis T. Xirouchakis P.

International Journal of Production Research, Vol. 39, Iss. 6, 2001-04 ,pp. : 1203-1220

Taylor & Francis Ltd

Access to resources Recommend Favorite

Evaluating the end-of-life value of a product andimproving it by redesign

By Pnueli Y. Zussman E.

International Journal of Production Research, Vol. 35, Iss. 4, 1997-04 ,pp. : 921-942

Taylor & Francis Ltd

Access to resources Recommend Favorite

Eco-architecture analysis for end-of-life decision making

By Kwak Min Jung

International Journal of Production Research, Vol. 47, Iss. 22, 2009-01 ,pp. : 6233-6259

Taylor & Francis Ltd

Access to resources Recommend Favorite

Configuration analysis to support product redesign for end-of-life disassembly

By Viswanathan S. Allada V.

International Journal of Production Research, Vol. 39, Iss. 8, 2001-05 ,pp. : 1733-1753

Taylor & Francis Ltd

Access to resources Recommend Favorite